ATE66152T1 - Reaktionsverbindung von 9-(2-hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem albumin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. - Google Patents

Reaktionsverbindung von 9-(2-hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem albumin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.

Info

Publication number
ATE66152T1
ATE66152T1 AT86114557T AT86114557T ATE66152T1 AT E66152 T1 ATE66152 T1 AT E66152T1 AT 86114557 T AT86114557 T AT 86114557T AT 86114557 T AT86114557 T AT 86114557T AT E66152 T1 ATE66152 T1 AT E66152T1
Authority
AT
Austria
Prior art keywords
hydroxyethoxymethyl
guanine
human albumin
preparation
lactosamined
Prior art date
Application number
AT86114557T
Other languages
English (en)
Inventor
Massimo Baldacci
Luigi Fiume
Corrado Busi
Alessandro Mattioli
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Application granted granted Critical
Publication of ATE66152T1 publication Critical patent/ATE66152T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86114557T 1985-10-21 1986-10-21 Reaktionsverbindung von 9-(2-hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem albumin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. ATE66152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8522559A IT1207507B (it) 1985-10-21 1985-10-21 Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
EP86114557A EP0220657B1 (de) 1985-10-21 1986-10-21 Reaktionsverbindung von 9-(2-Hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem Albumin, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
ATE66152T1 true ATE66152T1 (de) 1991-08-15

Family

ID=11197826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86114557T ATE66152T1 (de) 1985-10-21 1986-10-21 Reaktionsverbindung von 9-(2-hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem albumin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.

Country Status (6)

Country Link
US (1) US4725672A (de)
EP (1) EP0220657B1 (de)
AT (1) ATE66152T1 (de)
DE (1) DE3680857D1 (de)
ES (1) ES2037654T3 (de)
IT (1) IT1207507B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245217B (it) * 1991-03-12 1994-09-13 Baldacci Lab Spa Coniugato di azidotimidina ed albumina umana procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
IT1256110B (it) * 1992-11-23 1995-11-28 Procedimento di coniugazione di nucleosidi antivirali con albumina umana lattosaminata
ITMI20010027A1 (it) * 2001-01-10 2002-07-10 Uni Di Bologna Dipartimento Di Composizioni teraputiche per una chemioterapia locoregionale non invasiva delle micrometastasi epatiche
US20140271772A1 (en) * 2013-03-15 2014-09-18 Barry J. Margulies Biodegradable subcutaneous implants and methods of making

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
IT1177381B (it) * 1984-12-11 1987-08-26 Baldacci Lab Spa Metodo per la preparazione di coniugati della adenina-9-beta-d-arabino furano-side 5' monofosfato con albumina umana lattosaminata, coniugati risultanti e relative composizioi terapeuticamente attive

Also Published As

Publication number Publication date
EP0220657A2 (de) 1987-05-06
IT1207507B (it) 1989-05-25
US4725672A (en) 1988-02-16
DE3680857D1 (de) 1991-09-19
EP0220657A3 (en) 1988-10-05
ES2037654T3 (es) 1993-07-01
IT8522559A0 (it) 1985-10-21
EP0220657B1 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
NO169958C (no) Fremgangsmaate for fremstilling av et konjugat av et antitumorlegemiddel
KR950702181A (ko) 20-위치가 변형된 비타민 D계열의 유도체, 이들의 제조 방법, 이 제조 방법을 위한 중간 생성물, 이들 유도체를 함유하는 제약 제제, 및 약제 제조를 위한 이들의 용도(Derivatives in the Vitamin D Series Modified at the 20 Position a Method of Preparing Such Derivatives, Intermediates Used in This Method, Pharmaceutical Preparations Containing the Derivatives and Their Use in the Preparation of Drugs)
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
FR2634483B2 (fr) Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
ATE45580T1 (de) 9-(2-hydroxyethoxymethyl)guanin-derivate.
ATE74900T1 (de) Valproe- und (e)-2-valproensaeureabkoemmlinge, verfahren zu deren herstellung und pharmazeutische zusammensetzungen davon.
NO179163C (no) Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse
DK62187D0 (da) Farmaceutisk praeparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
DE68918406D1 (de) Xanthinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
BE885555A (fr) Preparations pharmaceutiques a activite cytostatique, nouveaux derives de l'acide isocyanurique et procedes pour leur preparation
PT86232A (en) Process for preparing a pharmaceutical composition containing a9-substituted guanine
ATE66152T1 (de) Reaktionsverbindung von 9-(2-hydroxyethoxymethyl)-guanin mit lactosaminiertem menschlichem albumin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE58538T1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
ATE25679T1 (de) Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung.
ATE55250T1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
DE3789290D1 (de) Theophyllinmethyldithiolan und Theophyllinmethyldithianylderivate, ein Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
EP0411268A3 (en) Dibenzo(1,5)dioxocin-5-on derivatives, their use in medicines and process for their preparation
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
ATE89744T1 (de) Pharmazeutische zusammensetzung.
LTIP1682A (en) Novel 16,17-acetal-substituted derivatives of pregnan-21-oic acid, process for preparing thereof, pharmaceutical preparations containing them
DE184838T1 (de) Konjugate von adenin-9-beta-arabinofuranosid-5'-monophosphat mit menschlichem lactosaminiertem albumin, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
FR2457275A1 (fr) Acides p-biphenyl-4 methyl-2 buten-3 oiques utiles dans le traitement des rhumatismes
RU1779254C (ru) Способ получени производных индоло /2,3-в/-хиноксалина
OA09379A (fr) Polyméthylène-imines disubstituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.